ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,748.99
      0.18%
      US Tech 100
      19,505.60
      -0.11%
      Dow Jones
      42,543.26
      -0.08%
      Brent Oil
      70.795
      2.10%
      Bitcoin
      89,795.47
      -0.15%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Takeda Pharmaceutical Company Ltd (TAK) Quote

      Takeda Pharmaceutical Company Ltd

      Takeda Pharmaceutical Company Ltd (TAK)

      Taku Gold Corp
      15.00
      -0.04
      (-0.27%)
      Closed March 06 4:00PM
      Delayed by 15 minutes
      15.07
      0.07
      ( 0.47% )
      Pre Market: 9:26AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      15.07
      Bid
      -
      Ask
      -
      Volume
      2,495
      0.00 Day's Range 0.00
      12.575 52 Week Range 15.155
      Market Cap
      47.29B
      Previous Close
      15.00
      Open
      -
      Last Trade
      60
      @
      15.09
      Last Trade Time
      08:57:31
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,740,927
      Shares Outstanding
      3,138,026,928
      Dividend Yield
      4.10%
      PE Ratio
      1.07
      Earnings Per Share (EPS)
      45.91
      Revenue
      4.28T
      Net Profit
      144.07B

      About Takeda Pharmaceutical Company Ltd

      Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Diversified
      Website
      www.takeda.co.jp
      Headquarters
      Chuo, Tokyo, Jpn
      Founded
      1984
      Takeda Pharmaceutical Company Ltd is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker TAK. The last closing price for Takeda Pharmaceutical was $15. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of $ 12.575 to $ 15.155.

      Takeda Pharmaceutical currently has 3,138,026,928 shares outstanding. The market capitalization of Takeda Pharmaceutical is $47.07 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 1.07.

      Ask ADVFN Intelligence (AI)

      TAK Latest News

      More News

      Form 13F-HR - Quarterly report filed by institutional managers, Holdings
      Edgar (US Regulatory)
      February 12 2025
      TAK (-0.27%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.725.0174216027914.3515.15514.325170534414.83855096DR
      41.4710.808823529413.615.15513.185144139114.14777673DR
      121.5811.712379540413.4915.15512.86174092713.50350101DR
      260.241.6183412002714.8315.15512.86171438413.80197167DR
      520.32.0311442112414.7715.15512.575178624113.74438033DR
      1560.231.5498652291114.8417.1512.28218077214.47273582DR
      260-2.43-13.885714285717.52012.28216889815.2967473DR

      TAK - Frequently Asked Questions (FAQ)

      What is the current Takeda Pharmaceutical share price?
      The current share price of Takeda Pharmaceutical is $ 15.07
      How many Takeda Pharmaceutical shares are in issue?
      Takeda Pharmaceutical has 3,138,026,928 shares in issue
      What is the market cap of Takeda Pharmaceutical?
      The market capitalisation of Takeda Pharmaceutical is USD 47.07B
      What is the 1 year trading range for Takeda Pharmaceutical share price?
      Takeda Pharmaceutical has traded in the range of $ 12.575 to $ 15.155 during the past year
      What is the PE ratio of Takeda Pharmaceutical?
      The price to earnings ratio of Takeda Pharmaceutical is 1.07
      What is the cash to sales ratio of Takeda Pharmaceutical?
      The cash to sales ratio of Takeda Pharmaceutical is 0.04
      What is the reporting currency for Takeda Pharmaceutical?
      Takeda Pharmaceutical reports financial results in JPY
      What is the latest annual turnover for Takeda Pharmaceutical?
      The latest annual turnover of Takeda Pharmaceutical is JPY 4.28T
      What is the latest annual profit for Takeda Pharmaceutical?
      The latest annual profit of Takeda Pharmaceutical is JPY 144.07B
      What is the registered address of Takeda Pharmaceutical?
      The registered address for Takeda Pharmaceutical is 4-1-1 DOSHOMACHI, CHUO-KU, CHUO, TOKYO, 540-8645
      What is the Takeda Pharmaceutical website address?
      The website address for Takeda Pharmaceutical is www.takeda.co.jp
      Which industry sector does Takeda Pharmaceutical operate in?
      Takeda Pharmaceutical operates in the PHARMACEUTICAL DIVERSIFIED sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAMAA Mission Acquisition Corp
      $ 10.2245
      (0.00%)
      		0
      AACT.UAres Acquisition Corporation II
      $ 11.05
      (0.00%)
      		0
      AACTAres Acquisition Corporation II
      $ 11.095
      (0.00%)
      		3
      AAAlcoa Corporation
      $ 32.83
      (0.00%)
      		33.64k
      AAgilent Technologies
      $ 126.55
      (0.00%)
      		396
      AAMAA Mission Acquisition Corp
      $ 10.2245
      (0.00%)
      		0
      AACT.UAres Acquisition Corporation II
      $ 11.05
      (0.00%)
      		0
      AACTAres Acquisition Corporation II
      $ 11.095
      (0.00%)
      		3
      AAAlcoa Corporation
      $ 32.83
      (0.00%)
      		33.64k
      AAgilent Technologies
      $ 126.55
      (0.00%)
      		396
      HPEHewlett Packard Enterprise Co
      $ 17.96
      (0.00%)
      		4.75M
      BBAIBigBear ai Holdings Inc
      $ 4.20
      (0.00%)
      		3.38M
      PCGPG&E Corporation
      $ 16.08
      (0.00%)
      		1.87M
      HALHalliburton Co
      $ 24.45
      (0.00%)
      		1.84M
      BABAAlibaba Group Holding Limited
      $ 139.95
      (0.00%)
      		1.81M

      TAK Discussion

      View Posts
      Monksdream Monksdream 11 months ago
      TAK over $10
      👍️0
      Boing x 2 Boing x 2 2 years ago
      Just saying,

      https://www.takeda.com/newsroom/newsreleases/2022/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-us-food-and-drug-administration

      4 months or less until an answer. Expedited review is six months or less now. It was accepted Nov 22nd.

      Big if we get FDA apprvoval. ETF's in the know are sucking up shares.

      Other approved drug has serious side effects vs. ours.

      300M cases a year from mosquito bites.

      Boing X 2
      👍️0
      Phosphene Phosphene 4 years ago
      Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

      https://www.businesswire.com/news/home/20201208005955/en/Takeda%E2%80%99s-Pipeline-Has-Potential-to-Contribute-Significantly-to-Revenue-Growth-Over-Next-Decade
      👍️0
      Phosphene Phosphene 4 years ago
      Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO

      https://www.reuters.com/article/health-coronavirus-takeda-vaccines-idUSKBN27M0F7
      👍️0
      Phosphene Phosphene 4 years ago
      MIT-Takeda program launches

      Research projects will harness the power of artificial intelligence to positively impact human health.

      https://news.mit.edu/2020/mit-takeda-program-launches-research-ai-and-human-health-0618
      👍️0
      rising rising 7 years ago
      Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

      ADR is 3:1 - NICE!
      60 percent upside
      Added 36.83 US stock
      Added 29.38 US cash


      Not a bad deal!
      👍️0
      rising rising 7 years ago
      So how does the Shire shareholder make out on this deal?

      Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

      Where is the 60percent premium to Close of March 27 2018 at shire 128.87
      👍️0
      trendmkr trendmkr 9 years ago
      Takeda article: enGene Shines with a Host of Big Name Collaborations

      http://marketexclusive.com/engene-shines-with-a-host-of-big-name-collaborations/1281/
      👍️0

      Your Recent History

      NYSE
      TAK
      Takeda Pharmaceutical
      BIT
      F21331
      Vontobel Financial Produ...
      COIN
      GBTUSD
      Globatalent
      BIT
      F34616
      Vontobel Financial Produ...
      LSE
      87AP
      Euro.bk. 25
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads